[Combined conventional magnetic resonance, magnetic resonance angiography, and magnetic resonance cholangiopancreatography in the diagnosis and staging of pancreatic carcinoma]
- PMID: 9280938
[Combined conventional magnetic resonance, magnetic resonance angiography, and magnetic resonance cholangiopancreatography in the diagnosis and staging of pancreatic carcinoma]
Abstract
Purpose: This study was aimed to integrating MR CholangioPancreatography (MRCP) and MR Angiography (MRA) to conventional MR images in the diagnosis and resectability assessment of pancreatic adenocarcinoma.
Material and methods: Twenty-three consecutive patients with pancreatic adenocarcinoma (16 in the head and 7 in the body-tail region) were examined with MR. Conventional MR, 3D MRCP and venous and arterial MRA images were acquired to assess biliary and vascular involvement. Acquisition time never exceeded 40-45 minutes. The images were independently studied by two radiologists and the final reading was decided upon consensus among readers. Sixteen patients underwent surgery.
Results: The diagnosis was confirmed at surgery in 16 patients and at percutaneous biopsy in 7. Interreader agreement was considered high, with .83 interobserver variability. Pancreatic adenocarcinoma was found in all patients examined. Unresectability because of vascular involvement was correctly assessed in all patients but 1. Biliary obstruction was demonstrated in 13 patients, involving the biliary and pancreatic ducts in 9 and the biliary ducts only in 4.
Conclusion: Technical advances now permit the extensive application of MRI to the study of abdominal conditions. The combination of MRI, MRCP and MRA can provide most of the information needed for the diagnosis and resectability assessment of pancreatic adenocarcinoma, which can otherwise be obtained only performing three different exams.
Similar articles
-
Pancreatic adenocarcinoma: combination of MR imaging, MR angiography and MR cholangiopancreatography for the diagnosis and assessment of resectability.Eur Radiol. 1998;8(3):428-34. doi: 10.1007/s003300050407. Eur Radiol. 1998. PMID: 9510578
-
MR-cholangiopancreaticography (MRCP) and MR-angiography: morphologic changes with magnetic resonance imaging.Anticancer Res. 1999 Jul-Aug;19(4A):2451-8. Anticancer Res. 1999. PMID: 10470174
-
Role of endoscopic ultrasound and magnetic resonance imaging in the preoperative staging of pancreatic adenocarcinoma.Am J Gastroenterol. 2000 Aug;95(8):1926-31. doi: 10.1111/j.1572-0241.2000.02245.x. Am J Gastroenterol. 2000. PMID: 10950037
-
Radiologic diagnosis and staging of pancreatic ductal adenocarcinoma.Eur J Radiol. 2001 May;38(2):105-12. doi: 10.1016/s0720-048x(01)00295-9. Eur J Radiol. 2001. PMID: 11335092 Review.
-
MRI evaluation of pancreatic ductal adenocarcinoma: diagnosis, mimics, and staging.Abdom Radiol (NY). 2019 Mar;44(3):936-949. doi: 10.1007/s00261-018-1686-x. Abdom Radiol (NY). 2019. PMID: 29967986 Review.
Cited by
-
Diagnostic accuracy of different imaging modalities following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancer.Cochrane Database Syst Rev. 2016 Sep 15;9(9):CD011515. doi: 10.1002/14651858.CD011515.pub2. Cochrane Database Syst Rev. 2016. PMID: 27631326 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Medical